These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9322131)

  • 1. Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs.
    Geldmacher DS; Lerner AJ; Voci JM; Noelker EA; Somple LC; Whitehouse PJ
    J Geriatr Psychiatry Neurol; 1997 Jul; 10(3):99-104. PubMed ID: 9322131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.
    Brendel M; Sauerbeck J; Greven S; Kotz S; Scheiwein F; Blautzik J; Delker A; Pogarell O; Ishii K; Bartenstein P; Rominger A;
    J Alzheimers Dis; 2018; 65(3):793-806. PubMed ID: 30010116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of adult Down syndrome treated with selective serotonin re-uptake inhibitor for behavior disorders].
    Hirayama T; Kobayashi T; Fujita T; Fujino O
    No To Hattatsu; 2004 Sep; 36(5):391-4. PubMed ID: 15461027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes.
    Sepehry AA; Lee PE; Hsiung GY; Beattie BL; Jacova C
    Drugs Aging; 2012 Oct; 29(10):793-806. PubMed ID: 23079957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in Alzheimer's Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors?
    Elsworthy RJ; Aldred S
    J Alzheimers Dis; 2019; 69(3):651-661. PubMed ID: 31104017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV.
    Caballero J; Nahata MC
    Ann Pharmacother; 2005 Jan; 39(1):141-5. PubMed ID: 15562140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
    Rushton JL; Clark SJ; Freed GL
    Pediatrics; 2000 Jun; 105(6):E82. PubMed ID: 10835095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression.
    Bartels C; Wagner M; Wolfsgruber S; Ehrenreich H; Schneider A;
    Am J Psychiatry; 2018 Mar; 175(3):232-241. PubMed ID: 29179578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease.
    Chow TW; Pollock BG; Milgram NW
    Neuropsychiatr Dis Treat; 2007; 3(5):627-36. PubMed ID: 19300592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors in pregnancy.
    Bellissima V; Ververs TF; Visser GH; Gazzolo D
    Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy.
    Wade RL; Kindermann SL; Hou Q; Thase ME
    J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence of cognitive decline in dementia in adults with Down's syndrome.
    Devenny DA; Krinsky-McHale SJ; Sersen G; Silverman WP
    J Intellect Disabil Res; 2000 Dec; 44 ( Pt 6)():654-65. PubMed ID: 11115020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of the selective serotonin noradrenaline reuptake inhibitor milnacipran on depressive symptoms in patients with Alzheimer's disease.
    Mizukami K; Hatanaka K; Tanaka Y; Sato S; Asada T
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):349-52. PubMed ID: 19166899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serotonin reuptake inhibitors in depression of Alzheimer's disease and other dementias].
    Lebert F
    Presse Med; 2003 Jul; 32(25):1181-6. PubMed ID: 13677882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.